Nov 28 (Reuters) - Vita Life Sciences Ltd (VLS) :
- SEES FY2022 PRE-TAX PROFIT OF A$9.5-10.0M
- SEES SALES OF A$64.0 MILLION-A$65.0 MILLION FOR FY22
- MARKET CONDITIONS ACROSS COMPLEMENTARY MEDICINE CATEGORIES CONTINUE TO REMAIN STRONG
- SOFTER TRADING CONDITIONS ARE EXPECTED IN 1H2023 ACROSS COMPLEMENTARY MEDICINE CATEGORIES
Nov 28 (Reuters) - Vita Life Sciences Ltd (VLS) : SEES FY2022...
Add to My Watchlist
What is My Watchlist?